Serotonin Syndrome Risk with Bupropion and SSRI Combination

Clinical Presentation and Risk Factors

Serotonin syndrome typically presents within 24-48 hours with a triad of mental status changes, neuromuscular hyperactivity, and autonomic instability, and can be misinterpreted as worsening depression, leading to inappropriate escalation of serotonergic medications and potentially fatal outcomes, according to the American College of Clinical Pharmacology 1
A critical pitfall is misinterpreting early serotonin syndrome symptoms as worsening depression, which can lead to inappropriate escalation of serotonergic medications and progression to severe toxicity with seizures, arrhythmias, and potentially fatal outcomes, as noted by the American College of Clinical Pharmacology 1

Bupropion has significantly lower rates of sexual dysfunction compared to SSRIs, making it a valuable augmentation strategy when sexual side effects are problematic, as recommended by the American Family Physician 2, 3, 4

Start the second medication at a low dose and increase slowly, with particularly close monitoring during the first 24-48 hours after any dosage changes, as advised by the American College of Clinical Pharmacology 1
Educate patients to immediately report confusion, agitation, tremor, muscle rigidity, fever, or rapid heart rate, which warrant immediate medication discontinuation and emergency evaluation, according to the American College of Clinical Pharmacology 1
Avoid adding additional serotonergic agents, such as tramadol, trazodone, triptans, dextromethorphan, or St. John's Wort, as these significantly amplify serotonin syndrome risk, as warned by the Mayo Clinic Proceedings 5, 1

Immediately discontinue all serotonergic medications if serotonin syndrome is suspected, and initiate hospital-based supportive care, including continuous cardiac monitoring, IV fluids, and benzodiazepines, as recommended by the American College of Clinical Pharmacology 1
Consider cyproheptadine for moderate to severe cases, with intensive care monitoring for severe presentations, according to the American College of Clinical Pharmacology 1

The American Academy of Child and Adolescent Psychiatry notes that mental status changes, such as confusion, agitation, anxiety, and delirium, are symptoms of serotonin syndrome 6
The Annals of Internal Medicine reports that neuromuscular hyperactivity, including tremor, clonus, hyperreflexia, and muscle rigidity, and autonomic instability, such as hyperthermia, diaphoresis, tachycardia, and diarrhea, are also symptoms of serotonin syndrome 7

The Annals of Internal Medicine recommends avoiding the simultaneous administration of high doses of both medications during the transition phase to minimize the risk of serotonin syndrome 7

The Journal of the American Academy of Child and Adolescent Psychiatry suggests that patients should be instructed to immediately report symptoms such as confusion, agitation, tremor, muscle rigidity, fever, or rapid heartbeat, which may require immediate medication discontinuation and emergency evaluation 6